ProMIS Neurosciences, Inc. (PMN)

EBITDA Margin

0.00%

Quarterly · Period ending:

PMN logo

PMN EBITDA Margin

Latest reported0.00%
PMN Quarterly EBITDA Margin (-22036.89% → 0.00%)
High-resolution chart · PNG

PMN ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

ProMIS Neurosciences, Inc. EBITDA Margin — Quarterly
Period endingEBITDA Margin
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
233,944.1275%
0%
0%
-47,289.1592%
-51,672.0271%
-20,614.9513%
0%
0%
0%
0%
-105,338.6581%
0%
-120,619.4676%
-14,873,398.9842%
-7,427,433.9286%
8,965,794.8666%
-745,153.8105%
-1,106,560.3866%
0%
-31,104,075.5093%
-367,137.1179%
-14,453.8188%
-3,901,428.3289%
-155,927.0517%
-420,000%
0%
0%
-20,514.8833%
44,939.265%
-6,845.6519%
-25,296.9121%
-2,774.9649%
-814.3368%
-1,070.543%
-675.0963%
-1,442.1259%
-1,214.6597%
-1,847.4029%
-1,661.8878%
-1,956.2901%
-3,172.7413%
-72,626.6325%
-35,401.2315%
-35,115.455%
-3,850.8585%
-49.0334%
-1,512.9119%
-1,343.0733%
-7,868.5248%
9.6741%
-6,580.3476%
-3,999.5371%
-1,554.3538%
-3,247.4069%
-2,736.4792%
-2,451.3226%
-1,753.48%
-1,855.8379%
-2,050.2912%
-1,814.1613%
-12,995.3917%
-1,575.8492%
-1,301.5048%
-2,164.8274%
-1,286.5023%
-1,342.7035%
-1,574.5837%
-3,239.0219%
-2,970.6703%
-12,684.4298%
-22,036.8946%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.